JO
IMNM icon

John Overdeck’s Immunome IMNM Stock Holding History

John Overdeck’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$507K Buy
+23,941
New +$512K ﹤0.01% 4154
2025
Q3 		– Sell
-26,654
Closed -$248K – 3781
2025
Q2 		$248K Sell
26,654
-63,070
-70% -$517K ﹤0.01% 2853
2025
Q1 		$604K Sell
89,724
-64,743
-42% -$621K ﹤0.01% 2438
2024
Q4 		$1.64M Buy
+154,467
New +$1.87M ﹤0.01% 1855
2024
Q3 		– Sell
-107,846
Closed -$1.3M – 3223
2024
Q2 		$1.3M Buy
+107,846
New +$1.69M ﹤0.01% 1834
2021
Q3 		– Sell
-29,516
Closed -$511K – 4459
2021
Q2 		$511K Buy
+29,516
New +$652K ﹤0.01% 3079

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

John Overdeck's IMNM Position: Q2 2026 in Review

John Overdeck opened a new position in Immunome (IMNM) in Q2 2026: 23,941 shares worth $507K. The stake represents ﹤0.01% of the portfolio and ranks #4154 among its holdings. This is a return to the name: John Overdeck previously reported a position in IMNM as recently as Q2 2025.

John Overdeck first reported a position in IMNM in Q2 2021 and has held it in 6 quarters since. The position peaked at $1.64M in Q4 2024. 200 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • John Overdeck held 23,941 shares of Immunome worth $507K as of Q2 2026.
  • Immunome was a new John Overdeck position in Q2 2026.
  • Immunome made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #4154 holding.
  • John Overdeck first reported a position in Immunome in Q2 2021 and has held it in 6 quarters since.
  • John Overdeck's Immunome position peaked at $1.64M in Q4 2024.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.